Adherex Technologies Inc. (FENC) Announces Earnings Results

Adherex Technologies Inc. (NASDAQ:FENC) issued its quarterly earnings results on Monday. The company reported ($0.15) earnings per share (EPS) for the quarter, RTT News reports. During the same period in the prior year, the firm posted ($0.04) earnings per share.

Shares of Adherex Technologies (NASDAQ:FENC) traded up $0.20 during mid-day trading on Tuesday, reaching $10.18. The company’s stock had a trading volume of 5,600 shares, compared to its average volume of 39,021. Adherex Technologies has a 52 week low of $8.00 and a 52 week high of $13.95.

ILLEGAL ACTIVITY WARNING: “Adherex Technologies Inc. (FENC) Announces Earnings Results” was reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/11/14/adherex-technologies-inc-fenc-announces-earnings-results.html.

About Adherex Technologies

Fennec Pharmaceuticals Inc, formerly Adherex Technologies Inc, is a biopharmaceutical company focused on cancer therapeutics. The Company’s lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children.

Receive News & Ratings for Adherex Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adherex Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply